Signifikans ApS   Report issue

For profit Phase 2
Founded: Vedbaek Denmark (2002)

Organization Overview

First Clinical Trial
2010
NCT01077466
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now